Two health care companies priced their delayed IPOs this week to raise a combined $132 million. In other IPO news, Snap broke below its issue price and the pipeline saw new filings from a high-growth retailer and a fracker, along with an energy withdrawal. Six...read more
Co-Diagnostics, which is commercializing diagnostic equipment for DNA tests, raised $7.1 million on Wednesday by offering 1.18 million shares at $6.00. At IPO, the pre-revenue company commanded a fully diluted market cap of $68 million. It originally...read more
Two health care deals are on the IPO calendar to raise a combined $134 million in the week ahead. Both companies had originally planned to price in the final week of June.
Akcea Therapeutics (AKCA), which was originally scheduled for June ...read more
Co-Diagnostics, which is commercializing diagnostic equipment for DNA tests, announced terms for its IPO on Friday. The Salt Lake City, UT-based company plans to raise $9 million by offering 1.3 million shares at a price range of $6.35 to $6.75. At the...read more
US IPO Weekly Recap: 2 health care companies price, Snap breaks
Two health care companies priced their delayed IPOs this week to raise a combined $132 million. In other IPO news, Snap broke below its issue price and the pipeline saw new filings from a high-growth retailer and a fracker, along with an energy withdrawal. Six...read more
Into the gene tool: Co-Diagnostics prices $7 million IPO below the range at $6
Co-Diagnostics, which is commercializing diagnostic equipment for DNA tests, raised $7.1 million on Wednesday by offering 1.18 million shares at $6.00. At IPO, the pre-revenue company commanded a fully diluted market cap of $68 million. It originally...read more
US IPO Week Ahead: Two health care companies scheduled for a slow week
Two health care deals are on the IPO calendar to raise a combined $134 million in the week ahead. Both companies had originally planned to price in the final week of June. Akcea Therapeutics (AKCA), which was originally scheduled for June ...read more
Microcap medical device company Co-Diagnostics sets terms for $9 million IPO
Co-Diagnostics, which is commercializing diagnostic equipment for DNA tests, announced terms for its IPO on Friday. The Salt Lake City, UT-based company plans to raise $9 million by offering 1.3 million shares at a price range of $6.35 to $6.75. At the...read more